Table 1 HeMoVal study assessment table. Overview of the different study periods (enrollment, baseline assessment, monitoring, 3-months follow-up, measurements) with the corresponding time schedule and assessments

Time

Hospital admission

Study inclusion

Daily after inclusion for max. 14 days postSAH

+ 12 weeks after event (+/− 2 weeks)

N/A

Eligibility Criteria

x

Patient information & consenting

x

Demographic/baseline measures

x

CSF-sampling

x (daily, if EVD/LD)

aVSP

x (daily, if imaging)

DCI

x (daily, if imaging)

DIND

x (daily, if assessable)

Spasmolysis

x (daily)

Intracerebroventricular rtPA

x (daily)

Triple H therapy

x (daily)

Surgical decompression

x (daily)

Nimodipine therapy

x (daily)

CSF infection

x (daily)

Surgical site infection

x (daily)

Chronic hydrocephalus

x

GOSE

x

mRS

x

Hematoma volume

x

CSF-Hb

x